Influence of medical conditions on the diagnostic accuracy of plasma p‐tau217 and p‐tau217/Aβ42
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.14430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Marcos Olvera-Rojas und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada…. Hauptthemen laut MEDLINE: tau Proteins, Amyloid beta-Peptides, Peptide Fragments, Brain. Die Arbeit wurde bisher 40-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIA NIH HHS, Clinical and Translational Science Institute at the University of Pittsburgh, NIH HHS.
Abstract (Originalsprache)
INTRODUCTION Blood‐based biomarkers (BBMs) can enable early detection of brain amyloid beta (Aβ) pathology in cognitively unimpaired individuals. However, the extent to which common medical conditions affect biomarker performance remains unclear. METHODS Participants ( n = 348) included individuals without cognitive impairment. We studied how brain Aβ associated with BBMs (Aβ42/40, phosphorylated tau [p‐tau] 181 and 217, p‐tau217/Aβ42, glial fibrillary acidic protein [GFAP], and neurofilament light [NfL]) and optimal BBM thresholds for predicting brain Aβ positivity and whether they are obscured by the presence of common medical conditions. RESULTS Plasma Aβ42/40, p‐tau181, p‐tau217, and GFAP, but not NfL, were significantly associated with brain Aβ. P‐tau217/Aβ42 showed the best discriminative performance (area under the curve: 0.91). The strength of p‐tau217–brain Aβ associations were obscured by diabetes and cardiovascular conditions. DISCUSSION These results suggest BBMs may help detect early Aβ pathology but suggest caution in their use due to common medical conditions that could affect accuracy. Highlights Plasma Aβ42/40, p‐tau181, p‐tau217, and GFAP but not NfL showed significant associations with brain Aβ. BBMs were more strongly associated with the level of brain Aβ in those without diabetes and cardiovascular conditions. P‐tau217/Aβ42 showed the best performance (AUC = 0.91) in discriminating Aβ presence with an optimal cut‐off of >1.2, followed by p‐tau217 at >0.46 pg/mL, with performance slightly improving when excluding participants with cardiovascular conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada, Spain.
- AdventHealth Research Institute, Orlando, Florida, USA.
- Centre for Healthy Ageing, Health Futures Institute, Murdoch University, Murdoch, Western Australia, Australia.
- Department of Psychiatry, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- Department of Psychiatry, Weill Cornell Medicine, New York, New York, USA.
- University of Kansas Alzheimer's Disease Research Center, Kansas City, Kansas, USA.
ORCID-Profile: Marcos Olvera-Rojas
Förderung
- NIA NIH HHS
- Clinical and Translational Science Institute at the University of Pittsburgh
- NIH HHS
- Kansas University
- NIMH NIH HHS
- NCATS NIH HHS
- National Institutes of Health
- University of Kansas
Zitieren
APA
Olvera-Rojas, M., Sewell, K. R., Karikari, T. K., Huang, H., Oberlin, L. E., Zeng, X., Morris, J. K., Collins, A. M., Drake, J. A., Sutton, B. P., Kramer, A. F., Hillman, C. H., Vidoni, E. D., Burns, J. M., Kamboh, M. I., McAuley, E., Marsland, A. L., Chen, Y., Lafferty, T. K., …, & Erickson, K. I. (2025). Influence of medical conditions on the diagnostic accuracy of plasma p‐tau217 and p‐tau217/Aβ42. Alzheimer's & Dementia. https://doi.org/10.1002/alz.14430
Vancouver
Olvera-Rojas M, Sewell KR, Karikari TK, Huang H, Oberlin LE, Zeng X, et al. Influence of medical conditions on the diagnostic accuracy of plasma p‐tau217 and p‐tau217/Aβ42. Alzheimer's & Dementia. 2025. doi:10.1002/alz.14430
BibTeX
@article{OlveraRojas2025,
author = {Olvera-Rojas, Marcos and Sewell, Kelsey R and Karikari, Thomas K and Huang, Haiqing and Oberlin, Lauren E and Zeng, Xuemei and Morris, Jill K and Collins, Audrey M and Drake, Jermon A and Sutton, Bradley P and Kramer, Arthur F and Hillman, Charles H and Vidoni, Eric D and Burns, Jeffrey M and Kamboh, M Ilyas and McAuley, Edward and Marsland, Anna L and Chen, Yijun and Lafferty, Tara K and Sehrawat, Anuradha and Jakicic, John M and Wan, Lu and Kang, Chaeryon and Erickson, Kirk I},
title = {Influence of medical conditions on the diagnostic accuracy of plasma p‐tau217 and p‐tau217/Aβ42},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.14430}
}
EUVIMED